Article
Midostaurin in Combination With Standard Chemotherapy for Treatment of Newly Diagnosed FMS-Like Tyrosine Kinase 3 (FLT3) Mutation-Positive Acute Myeloid Leukemia.
The Annals of pharmacotherapy - 1 Apr 2018
Kim Miryoung, Williams Sherry
Abstract excerpt
OBJECTIVE: To evaluate the efficacy and safety of midostaurin in combination with standard cytarabine and daunorubicin induction and cytarabine consolidation in newly diagnosed FLT3-mutated acute myeloid leukemia (AML). DATA SOURCE: A literature search of PubMed and MEDLINE (September 2017) was p...
Topics
- Antineoplastic Agents
- Antineoplastic Combined Chemotherapy Protocols
- Cytarabine
- Daunorubicin
- Humans
- Leukemia, Myeloid, Acute
- Mutation
- Protein Kinase Inhibitors
- Staurosporine
- Treatment Outcome
- fms-Like Tyrosine Kinase 3